Recent Work
A 340B transaction involves more than a manufacturer selling pharmaceuticals and a covered entity buying them. Because the transaction involves many parties, even when both the manufacturer and covered entity are processing transactions correctly on their respective ends, compliance can still hit a snag.
Read MoreManufacturers are struggling with how best to respond to the increasing volume of 340B self-reporting offers and checks from Covered Entities. In response, CiiTA is pleased to introduce the Manufacturer 340B Self-Reporting Assistance offering. CiiTA assists manufacturers by providing guidance and data analysis to support investigation into events triggering self-reporting letters and refund checks. Our…
Read MoreDevelop Your 340B Strategy
CiiTA has, through extensive experience, developed a set of best practices to help guide you through the creation of your 340B strategy. Download our process document to facilitate the development of your strategy.